Daihan Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	47,149	43,973	61,302	101,501	90,857	83,765
Short-Term Investments	9,851	3,962	8,934	2,858	6,750	12,650
Trading Asset Securities	41,660	41,600	7,000	-	-	-
Cash & Short-Term Investments	98,660	89,535	77,237	104,359	97,607	96,415
Cash Growth	-7.81%	15.92%	-25.99%	6.92%	1.24%	42.63%
Accounts Receivable	30,029	31,001	31,225	30,857	31,306	29,101
Other Receivables	1,507	2,978	1,347	85.13	932.21	71.32
Receivables	31,536	33,979	32,572	30,942	32,238	29,172
Inventory	35,142	33,933	26,735	23,588	24,939	20,632
Prepaid Expenses	90.46	90.71	82.8	79.94	74.87	107.4
Other Current Assets	2,065	954.1	739.83	935.43	1,026	1,212
Total Current Assets	167,494	158,492	137,366	159,905	155,886	147,539
Property, Plant & Equipment	152,120	153,399	134,441	125,853	113,236	113,831
Long-Term Investments	32,854	35,342	52,175	8,065	7,394	10,129
Other Intangible Assets	397.01	397.01	397.01	397.01	397.01	397.01
Long-Term Accounts Receivable	0	-0	0	-	0	-
Long-Term Deferred Tax Assets	-	-	-	-	-	398.84
Other Long-Term Assets	32.6	32.74	32.18	33	67.34	247.34
Total Assets	352,897	347,663	324,411	294,252	276,980	272,542
Accounts Payable	18,473	17,754	17,753	17,227	18,104	15,108
Accrued Expenses	608.36	818.71	795.63	777.66	739.86	674.52
Short-Term Debt	-	-	-	-	2,500	2,700
Current Portion of Long-Term Debt	-	-	-	-	-	6,800
Current Portion of Leases	29.98	13.26	26.27	-	-	16.57
Current Income Taxes Payable	3,226	2,386	4,357	4,466	5,130	5,662
Other Current Liabilities	24,050	22,535	19,712	18,830	16,211	15,158
Total Current Liabilities	46,429	43,508	42,644	41,300	42,686	46,119
Long-Term Debt	-	-	-	-	4,000	14,000
Long-Term Leases	18.42	-	2.76	-	-	-
Pension & Post-Retirement Benefits	3,365	1,921	4,626	4,080	3,555	9,109
Long-Term Deferred Tax Liabilities	783.92	899.94	555	303.87	775.87	-
Other Long-Term Liabilities	1,141	1,121	589.7	594.63	565.8	506.37
Total Liabilities	51,738	47,450	48,418	46,278	51,582	69,734
Common Stock	3,000	3,000	3,000	3,000	3,000	3,000
Additional Paid-In Capital	175.92	175.92	175.92	175.92	175.92	175.92
Retained Earnings	291,848	290,902	266,545	238,525	216,086	190,078
Treasury Stock	-3,418	-3,418	-3,418	-3,418	-3,418	-
Comprehensive Income & Other	9,554	9,554	9,691	9,691	9,554	9,554
Shareholders' Equity	301,159	300,214	275,994	247,974	225,398	202,808
Total Liabilities & Equity	352,897	347,663	324,411	294,252	276,980	272,542
Total Debt	48.4	13.26	29.03	-	6,500	23,517
Net Cash (Debt)	98,612	89,522	77,208	104,359	91,107	72,899
Net Cash Growth	-7.82%	15.95%	-26.02%	14.55%	24.98%	87.68%
Net Cash Per Share	-	15224.79	13130.53	17748.21	15223.16	12149.75
Filing Date Shares Outstanding	-	5.88	5.88	5.88	5.88	6
Total Common Shares Outstanding	-	5.88	5.88	5.88	5.88	6
Working Capital	121,065	114,985	94,722	118,604	113,200	101,420
Book Value Per Share	-	51056.74	46937.72	42172.46	38333.01	33801.34
Tangible Book Value	300,762	299,817	275,597	247,577	225,001	202,411
Tangible Book Value Per Share	-	50989.22	46870.20	42104.94	38265.49	33735.17
Land	59,385	59,385	59,385	59,380	56,796	55,727
Buildings	89,502	89,101	68,862	61,781	59,354	49,971
Machinery	109,745	108,690	86,007	81,358	78,438	77,615
Construction In Progress	2,199	1,948	18,158	15,484	3,225	8,857